Anita Dushyanth
Stock Analyst at Berenberg
(2.77)
# 1,956
Out of 4,761 analysts
4
Total ratings
75%
Success rate
15.74%
Average return
Main Sectors:
Stocks Rated by Anita Dushyanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Initiates: Buy | $20 | $10.08 | +98.41% | 1 | Apr 27, 2022 | |
| SERA Sera Prognostics | Initiates: Buy | $13 | $4.12 | +215.53% | 1 | Apr 27, 2022 | |
| BTAI BioXcel Therapeutics | Initiates: Buy | $1,200 | $2.13 | +56,238.03% | 1 | Apr 9, 2021 | |
| PCRX Pacira BioSciences | Initiates: Buy | $93 | $25.16 | +269.63% | 1 | Apr 9, 2021 |
UroGen Pharma
Apr 27, 2022
Initiates: Buy
Price Target: $20
Current: $10.08
Upside: +98.41%
Sera Prognostics
Apr 27, 2022
Initiates: Buy
Price Target: $13
Current: $4.12
Upside: +215.53%
BioXcel Therapeutics
Apr 9, 2021
Initiates: Buy
Price Target: $1,200
Current: $2.13
Upside: +56,238.03%
Pacira BioSciences
Apr 9, 2021
Initiates: Buy
Price Target: $93
Current: $25.16
Upside: +269.63%